Study Design - Non-alcoholic Steatohepatitis Clinical Trials Market
The global study design non-alcoholic steatohepatitis clinical trials market size was valued at US$ 2,922.9 million in 2024 and is estimated to grow at a compound annual growth rate (CAGR) of 6.3% from 2024 to 2030.